Investor Presentaiton
Non-IFRS Adjustments in EBITDA
Deferred Revenue Adjustments (Em)
Other non-IFRS Adjustments (Em)
Q3 20
Q3 19
9M 20
9M 19
Q3 20 Q3 19
9M 20
9M 19
Billings
106.5
82.7
332.1
224.3
Total IFRS 2 Charges
(13.8)
(26.2)
(34.2)
(27.1)
TeamViewer LTIP
Perpetual Def. Revenue
(0.6)
(1.0)
9.2
31.3
39.7
95.8
Release/(Addition)
Ubimax Share Consideration
(3.3)
(3.3)
Share-based Compensation by TLO
(9.9)
(26.2)
(29.9)
(27.1)
Subscription Def. Revenue
2.5
(11.6)
(34.7)
(35.4)
Release/(Addition)
Other Material Items
(2.4)
(11.9)
(3.4)
(16.0)
Financing, M&A, transaction-related
(0.9)
(0.5)
(1.1)
(0.6)
Unallocated Def. Revenue
(1.1)
(0.3)
(2.5)
(1.4)
Release/(Addition)
IPO related
(9.9)
0.0
(10.0)
Other
(1.5)
(1.6)
(2.3)
(5.4)
Revenue
117.2
102.0
334.6
283.3
USD Hedge Valuation Gain/Loss
1.3
1.1
Perpetual deferred revenue now largely released with €9.2m remaining on
balance sheet (see next page)
Total
(14.9)
(38.1) (36.5) (43.1)
.
Unallocated deferred revenue mainly consists of undue billings not
recognized as receivables under IFRS 15
•
TeamViewer cash-settled LTIP includes executive and key employee grants
Ubimax share consideration recognized under IFRS 2 due to vesting
condition with respect to continued employment of management
Share-based compensation by TigerLux One (TLO) are fully funded by the
selling shareholder in the IPO
21
21
Q3 2020 Investor Presentation
TeamViewerView entire presentation